News

A DNA/RNA hybrid molecule is able to enter lymphocytes and effectively silence disease-causing genes, suggesting it could be used as a therapeutic for autoimmune disorders.

Researchers have revealed that during the development of Type 1 Diabetes, the cells lining the pancreatic duct reprogram themselves in an attempt to suppress autoimmune T cell responses.

Scientists discovered that innate effector cells, as well as acting during the early stages of infection, can also be trained to develop an innate form of immunological memory that can protect the host during reinfection.

Extract from the bark of the Neem tree may help treat and reduce the spread of coronavirus, according to a new study led by scientists at the University of Colorado Anschutz Medical Campus and the Indian Institute of Science Education and Research Kolkata.

A strong desire to travel has contributed to an increase in COVID-19 vaccination rates, which could aid the travel industry's economic recovery.

UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed.

The grand prize winner of the inaugural Michelson Philanthropies & Science Prize for Immunology has illuminated factors that underlie varied susceptibilities to COVID-19.

With post-mining rehabilitation vital for the environment, researchers have used patterns in soil microbial communities to track progress and predict timeframes for recovery.

According to research, Several FDA-approved drugs significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells.

Investigators have identified a protein that plays a critical role in activating genes required for a critical developmental stage of the malaria parasite.